Startups
Balyasny Asset Management L.P.
Edit

Balyasny Asset Management L.P.

Trusted
http://www.bamfunds.com/
Last activity: 31.10.2026
Active
Categories: CultureFinTechFirmGrowthInvestmentManagementMarketOfficePlatformTalent
Balyasny Asset Management (BAM) is a global, multi-manager multi-strategy investment firm founded in 2001 by Dmitry Balyasny, Scott Schroeder and Taylor O'Malley. What began as a single, small office in Chicago trading mostly long/short equity has grown into an institutional global platform with investment strategies spanning across Equities Long/Short, Macro, Equities Arbitrage, Credit, Commodities, Systematic and Growth Equity. Today, we have 15 global offices with over 1,700 team members, 161 investment teams, and 21 partners managing more than $20 billion in AUM. We have built an award-winning collaborative culture dedicated to leveraging the collective knowledge and experience of our team members across industries, asset classes, regions, and markets to uncover profitable investment opportunities that deliver value to our clients. At BAM, we are our talent. We are a growing firm that offers a multitude of professional opportunities. Through BAM’s selective hiring process, we target the best and brightest in the business, and strive to create an environment which attracts and retains top talent. Maintaining a culture where people are energized to come to work is paramount to our success. Our team is motivated to perform each and every day. As a result, BAM has built a reputation as a firm that provides the tools necessary for talented individuals to achieve their goals and reach their highest potential.
Followers
71.52K
Website visits
68.5K /mo.
Mentions
28

Overview

Location
United States, Illinois, Chicago
Employees
1001-5000
Founded date
2001

Mentions in press and media 28

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Oct 30, 2026Kalshi raises $1 billion at $40 billion valuation as prediction market giant expands into financial tradingKalshi has raised $1 billion in fresh funding at a staggering $40 billion valuation, marking another milestone in the prediction market company’s rapid rise. But the bigger story isn’t the money. Kalshi is moving beyond betting on elections...
Oct 29, 2026Kalshi Raises $1 Billion Series G At $40 Billion Valuation For Prediction Market PlatformKalshi has raised $1 billion in Series G funding at a $40 billion post-money valuation as the prediction market company expands into a broader range of financial products and international markets. The round was co-led by Wellington and Seq...
Oct 26, 2026Options Action Cracking AI trade has Wall Street looking for a hedge. An ex-Citadel quant may have the answerJasper Zhang, ex-Citadel quant, runs Hyperbolic, a GPU exchange building software for “physical” GPU futures. The platform allows investors to buy and sell GPU clusters, the units that power AI compute. Zhang sees the technology as the firs...
Oct 23, 2026Zai Lab Raises $250 Million PIPE To Advance DLL3-Targeting ADC Zocilurtatug PelitecanZai Lab has entered into an agreement to raise approximately $250 million through a private investment in public equity financing, with proceeds primarily earmarked for the global development of its DLL3-targeting antibody-drug conjugate zo...
Oct 22, 2026Soufflé Therapeutics Secures $135M Series B to Propel RNA Therapy RevolutionBoston-based Soufflé Therapeutics secured an oversubscribed $135 million Series B financing, spearheaded by Juvia Group. This substantial investment propels the RNA therapeutics innovator. Soufflé leverages its proprietary REMEDY platform, ...
Oct 19, 2026Souffle Therapeutics Nets $135M Series B BOSTON, MA, Souffle Therapeutics, a leading RNA therapies company aimed at advancing the next generation of therapies designed to help people live healthier lives, announced the close of an oversubscribed $135 million Series B financing le...
Oct 2, 2026Hedge funds deliver mixed September results on AI swingsHONG KONG/NEW YORK, Oct 7 : Global hedge funds delivered mixed results in September after surging bond yields, higher oil prices and swings in AI shares drove selling, while quant strategies posted gains, according to prime brokerage notes ...
Aug 10, 2026Expedition Therapeutics Closes $115 Million Series B SAN FRANCISCO, CA, Expedition Therapeutics, a clinical-stage biotechnology company developing novel oral small molecule therapies for inflammatory and respiratory diseases, announced the closing of an oversubscribed $115 million Series B f...
Aug 9, 2026Expedition Therapeutics Lands $115M Series B SAN FRANCISCO, CA, Expedition Therapeutics has announced the closing of an oversubscribed $115 million Series B financing round. >> Click here for more funding data on Expedition Therapeutics >> To export Expedition Therapeutic...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Balyasny Asset Management L.P.

When was Balyasny Asset Management L.P. founded?

Balyasny Asset Management L.P. was founded in 2001.

What has the press written about Balyasny Asset Management L.P.?

Parsers VC has collected 28 articles mentioning Balyasny Asset Management L.P., among them “Kalshi raises $1 billion at $40 billion valuation as prediction market giant expands into financial trading” (Oct 30, 2026) and “Kalshi Raises $1 Billion Series G At $40 Billion Valuation For Prediction Market Platform” (Oct 29, 2026).

Is Balyasny Asset Management L.P. still active?

Yes, Balyasny Asset Management L.P. is active; its latest activity on Parsers VC dates from Oct 31, 2026.